BEMPEDOIC ACID (BA) PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL TO ASSESS THE BIOEQUIVALENCE (BE) OF BA ORAL SUSPENSION AND COMMERCIAL IMMEDIATE RELEASE (IR) TABLET FORMULATIONS IN A VIRTUAL POPULATION OF HEALTHY ADULTS.

被引：0

|

作者：

Amore, B. ^{[1
]}

Patel, N. ^{[2
]}

Batheja, P. ^{[1
]}

Greene, L. ^{[1
]}

Tatavarti, A. ^{[1
]}

机构：

[1] Esper Therapeut, Ann Arbor, MI USA

[2] Certara, Princeton, NJ USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2022年 / 111卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

P-008

引用

收藏

页码：S7 / S7

页数：1

相关论文

共 1 条

[1] Physiologically Based Pharmacokinetic Model Development and Verification for Bioequivalence Testing of Bempedoic Acid Oral Suspension and Reference Tablet Formulation
Amore, Benny M.
Patel, Nikunjkumar
Batheja, Priya
Templeton, Ian E.
Jones, Hannah M.
Louie, Michael J.
Emery, Maurice G.
PHARMACEUTICS, 2023, 15 (05)